UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 272

Sortiert nach

The efficacy of a third-generation oncolytic herpes simplex viral therapy for an HPV-related uterine cervical cancer model

International journal of clinical oncology, 2021-03, Vol.26 (3), p.591-597

2021

Volltextzugriff (PDF)

A mouse monoclonal antibody against influenza C virus attenuates acetaminophen-induced liver injury in mice

Scientific reports, 2021-06, Vol.11 (1), p.11816-14, Article 11816

2021

Volltextzugriff (PDF)

Treatment of HPV-Related Uterine Cervical Cancer with a Third-Generation Oncolytic Herpes Simplex Virus in Combination with an Immune Checkpoint Inhibitor

International journal of molecular sciences, 2023-01, Vol.24 (3), p.1988

2023

Volltextzugriff (PDF)

The relationship between the chemical structure, physicochemical properties, and mucosal adjuvanticity of sugar-based surfactants

European journal of pharmaceutics and biopharmaceutics, 2023-01, Vol.182, p.1-11

2023

Volltextzugriff (PDF)

A systematic assessment of the relationship between synthetic surfactants and mucosal adjuvanticity

European journal of pharmaceutics and biopharmaceutics, 2021-08, Vol.165, p.113-126

2021

Volltextzugriff (PDF)

Analysis of the beta-propiolactone sensitivity and optimization of inactivation methods for human influenza H3N2 virus

Journal of virological methods, 2016-09, Vol.235, p.105-111

2016

Volltextzugriff (PDF)

Materiality in Management Studies: Development of the Theoretical Frontier

1, 2022

Volltextzugriff (PDF)

Polymyxins as novel and safe mucosal adjuvants to induce humoral immune responses in mice

PloS one, 2013-04, Vol.8 (4), p.e61643

2013

Volltextzugriff (PDF)

Suitability of Polymyxin B as a Mucosal Adjuvant for Intranasal Influenza and COVID-19 Vaccines

Vaccines (Basel), 2023-11, Vol.11 (11), p.1727

2023

Volltextzugriff (PDF)

Optimization of trypsins for influenza A/H1N1 virus replication in MDCK SI-6 cells, a novel MDCK cell line

Journal of virological methods, 2018-02, Vol.252, p.94-99

2018

Volltextzugriff (PDF)

Critical micelle concentration and particle size determine adjuvanticity of cyclic lipopeptides

Scandinavian journal of immunology, 2018-08, Vol.88 (2), p.e12698-n/a

2018

Volltextzugriff (PDF)

Cocirculation of Influenza C Viruses with Distinct Internal Genome Constellations in Iwate Prefecture, Japan, in 2016

Japanese Journal of Infectious Diseases, 2018/09/30, Vol.71(5), pp.393-395

2018

Volltextzugriff (PDF)

Mast cells partially contribute to mucosal adjuvanticity of surfactin in mice

Immunity, Inflammation and Disease, 2018-03, Vol.6 (1), p.117-127

2018

Volltextzugriff (PDF)

The epitope sequence of S16, a monoclonal antibody against influenza C virus hemagglutinin-esterase fusion glycoprotein

Future virology, 2017-03, Vol.12 (3), p.93-101

2017

Volltextzugriff (PDF)

Enterotoxin-Based Mucosal Adjuvants Alter Antigen Trafficking and Induce Inflammatory Responses in the Nasal Tract

Infection and Immunity, 2005-10, Vol.73 (10), p.6892-6902

2005

Volltextzugriff (PDF)

Priming-Boosting Vaccination with Recombinant Mycobacterium bovis Bacillus Calmette-Guérin and a Nonreplicating Vaccinia Virus Recombinant Leads to Long-Lasting and Effective Immunity

Journal of Virology, 2005-10, Vol.79 (20), p.12871-12879

2005

Volltextzugriff (PDF)

Co-administration of cholera toxin and apple polyphenol extract as a novel and safe mucosal adjuvant strategy

Vaccine, 2009-07, Vol.27 (35), p.4808-4817

2009

Volltextzugriff (PDF)

Anti-V3 Humanized Antibody KD-247 Effectively Suppresses Ex Vivo Generation of Human Immunodeficiency Virus Type 1 and Affords Sterile Protection of Monkeys against a Heterologous Simian/Human Immunodeficiency Virus Infection

Journal of Virology, 2006-06, Vol.80 (11), p.5563-5570

2006

Volltextzugriff (PDF)

EP003/#550 Efficacy of combination chemotherapy and third-generation oncolytic herpes virus therapy for cervical cancer

International journal of gynecological cancer, 2023-11, Vol.33 (Suppl 4), p.A86-A86

2023

Volltextzugriff (PDF)

Mucosal Immune Responses in W/Wv and Sl/Sld Mutant Mice

Experimental Animals, 2012, Vol.61(4), pp.407-416

2012

Volltextzugriff (PDF)

Vaccination of Rhesus Macaques with Recombinant Mycobacterium bovis Bacillus Calmette-Guérin Env V3 Elicits Neutralizing Antibody-Mediated Protection against Simian-Human Immunodeficiency Virus with a Homologous but Not a Heterologous V3 Motif

Journal of Virology, 2005-02, Vol.79 (3), p.1452-1462

2005

Volltextzugriff (PDF)

Rule Management in High‑Risk Organizations: Reconsidering Research Agendas in Safety Management Studies

Organizational Science, 2018/03/20, Vol.51(3), pp.19-30

2018

Volltextzugriff (PDF)

A Novel Adjuvant for Mucosal Immunity to HIV-1 gp120 in Nonhuman Primates

The Journal of immunology (1950), 2004-12, Vol.173 (11), p.6850-6857

2004

Volltextzugriff (PDF)

Establishment of a cell model of X-linked sideroblastic anemia using genome editing

Experimental hematology, 2018-09, Vol.65, p.57-68.e2

2018

Volltextzugriff (PDF)

Expression of Functional Chemokine Receptors of Human Placental Cells

American journal of reproductive immunology (1989), 2000-12, Vol.44 (6), p.365-373

2000

Volltextzugriff (PDF)

1 – 25 von 272

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(206)
Mit Volltextzugriff
(232)

Publikationsform

Sprache

Englisch
(246)
Japanisch
(91)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The efficacy of a third-generation oncolytic herpes simplex viral therapy for an HPV-related uterine cervical cancer model

A mouse monoclonal antibody against influenza C virus attenuates acetaminophen-induced liver injury in mice

Treatment of HPV-Related Uterine Cervical Cancer with a Third-Generation Oncolytic Herpes Simplex Virus in Combination with an Immune Checkpoint Inhibitor

The relationship between the chemical structure, physicochemical properties, and mucosal adjuvanticity of sugar-based surfactants

A systematic assessment of the relationship between synthetic surfactants and mucosal adjuvanticity

Analysis of the beta-propiolactone sensitivity and optimization of inactivation methods for human influenza H3N2 virus

Materiality in Management Studies: Development of the Theoretical Frontier

Polymyxins as novel and safe mucosal adjuvants to induce humoral immune responses in mice

Suitability of Polymyxin B as a Mucosal Adjuvant for Intranasal Influenza and COVID-19 Vaccines

Optimization of trypsins for influenza A/H1N1 virus replication in MDCK SI-6 cells, a novel MDCK cell line

Critical micelle concentration and particle size determine adjuvanticity of cyclic lipopeptides

Cocirculation of Influenza C Viruses with Distinct Internal Genome Constellations in Iwate Prefecture, Japan, in 2016

Mast cells partially contribute to mucosal adjuvanticity of surfactin in mice

The epitope sequence of S16, a monoclonal antibody against influenza C virus hemagglutinin-esterase fusion glycoprotein

Enterotoxin-Based Mucosal Adjuvants Alter Antigen Trafficking and Induce Inflammatory Responses in the Nasal Tract

Priming-Boosting Vaccination with Recombinant Mycobacterium bovis Bacillus Calmette-Guérin and a Nonreplicating Vaccinia Virus Recombinant Leads to Long-Lasting and Effective Immunity

Co-administration of cholera toxin and apple polyphenol extract as a novel and safe mucosal adjuvant strategy

Anti-V3 Humanized Antibody KD-247 Effectively Suppresses Ex Vivo Generation of Human Immunodeficiency Virus Type 1 and Affords Sterile Protection of Monkeys against a Heterologous Simian/Human Immunodeficiency Virus Infection

EP003/#550 Efficacy of combination chemotherapy and third-generation oncolytic herpes virus therapy for cervical cancer

Mucosal Immune Responses in W/Wv and Sl/Sld Mutant Mice

Vaccination of Rhesus Macaques with Recombinant Mycobacterium bovis Bacillus Calmette-Guérin Env V3 Elicits Neutralizing Antibody-Mediated Protection against Simian-Human Immunodeficiency Virus with a Homologous but Not a Heterologous V3 Motif

Rule Management in High‑Risk Organizations: Reconsidering Research Agendas in Safety Management Studies

A Novel Adjuvant for Mucosal Immunity to HIV-1 gp120 in Nonhuman Primates

Establishment of a cell model of X-linked sideroblastic anemia using genome editing

Expression of Functional Chemokine Receptors of Human Placental Cells

Suchergebnisse filtern